Baidu
map

我国首台重离子治癌装置将投入临床

2016-05-03 刘晓倩 中国科学报

日前,甘肃重离子医院在武威召开临床试验方案研讨会。中、德、日三国放疗专家、物理师以及中科院近代物理研究所科研人员共同参会,研讨重离子治疗肿瘤临床试验方案。甘肃重离子医院表示,重离子治癌临床试验计划今年10月开始。 甘肃重离子医院院长叶延程介绍,目前医院各种设备和配套设施已到位,重离子专用装置正在进行检测测试,计划年底投入运营。 即将投入使用的医用重离子加速器由中科院近物所研发,是我

日前,甘肃重离子医院在武威召开临床试验方案研讨会。中、德、日三国放疗专家、物理师以及中科院近代物理研究所科研人员共同参会,研讨重离子治疗肿瘤临床试验方案。甘肃重离子医院表示,重离子治癌临床试验计划今年10月开始。

甘肃重离子医院院长叶延程介绍,目前医院各种设备和配套设施已到位,重离子专用装置正在进行检测测试,计划年底投入运营。

即将投入使用的医用重离子加速器由中科院近物所研发,是我国首台自主知识产权的“重离子治癌”装置。该装置将重离子加速器的同步加速环从科学实验用的160米缩短到56.2米,达到国际先进水平。

中科院近物所“重离子治癌”装置2012年落户武威。使中国成为继美国、德国、日本之后第四个开展该研究的国家。与以往的加速器放射治疗技术相比,重离子具有独特的物理和生物优势,在治疗过程中对患者的正常组织辐射损伤轻、疗程短、治愈效率高。截至2015年10月,全球接受重离子治癌的人数为15297人。

《中国科学报》 (2016-05-03 第4版 综合)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1748845, encodeId=30ac1e48845aa, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Mon Dec 19 18:21:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650624, encodeId=4e7f165062478, content=<a href='/topic/show?id=844c96012df' target=_blank style='color:#2F92EE;'>#重离子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96012, encryptionId=844c96012df, topicName=重离子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2824060557, createdName=jj000009, createdTime=Wed Jun 22 20:21:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84641, encodeId=10d8846417b, content=新技术的运用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Sun May 08 07:10:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83615, encodeId=b42183615f4, content=前沿, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86311671699, createdName=whwhah, createdTime=Tue May 03 19:48:00 CST 2016, time=2016-05-03, status=1, ipAttribution=)]
    2016-12-19 yinhl1990
  2. [GetPortalCommentsPageByObjectIdResponse(id=1748845, encodeId=30ac1e48845aa, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Mon Dec 19 18:21:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650624, encodeId=4e7f165062478, content=<a href='/topic/show?id=844c96012df' target=_blank style='color:#2F92EE;'>#重离子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96012, encryptionId=844c96012df, topicName=重离子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2824060557, createdName=jj000009, createdTime=Wed Jun 22 20:21:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84641, encodeId=10d8846417b, content=新技术的运用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Sun May 08 07:10:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83615, encodeId=b42183615f4, content=前沿, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86311671699, createdName=whwhah, createdTime=Tue May 03 19:48:00 CST 2016, time=2016-05-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1748845, encodeId=30ac1e48845aa, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Mon Dec 19 18:21:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650624, encodeId=4e7f165062478, content=<a href='/topic/show?id=844c96012df' target=_blank style='color:#2F92EE;'>#重离子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96012, encryptionId=844c96012df, topicName=重离子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2824060557, createdName=jj000009, createdTime=Wed Jun 22 20:21:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84641, encodeId=10d8846417b, content=新技术的运用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Sun May 08 07:10:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83615, encodeId=b42183615f4, content=前沿, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86311671699, createdName=whwhah, createdTime=Tue May 03 19:48:00 CST 2016, time=2016-05-03, status=1, ipAttribution=)]
    2016-05-08 Lisa971

    新技术的运用。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1748845, encodeId=30ac1e48845aa, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Mon Dec 19 18:21:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650624, encodeId=4e7f165062478, content=<a href='/topic/show?id=844c96012df' target=_blank style='color:#2F92EE;'>#重离子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96012, encryptionId=844c96012df, topicName=重离子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f2824060557, createdName=jj000009, createdTime=Wed Jun 22 20:21:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=84641, encodeId=10d8846417b, content=新技术的运用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Sun May 08 07:10:00 CST 2016, time=2016-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83615, encodeId=b42183615f4, content=前沿, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86311671699, createdName=whwhah, createdTime=Tue May 03 19:48:00 CST 2016, time=2016-05-03, status=1, ipAttribution=)]
    2016-05-03 whwhah

    前沿

    0

相关资讯

PTCOG 2014:质子重离子治疗肿瘤对话中外专家

本报上海6月12日(记者陈婕)在6月11日举行的媒体见面会上,第53届国际粒子肿瘤放射治疗大会主席蒋国梁教授和国际粒子肿瘤放射治疗组织主席尤金·B·霍克(Eugen B.Hug)教授共同接受了媒体记者的采访,解答了专业人士和公众感兴趣的质子重离子治疗肿瘤的热点问题。 Q1:如何选择适于质子重离子治疗的患者? Hug教授:理论上而言,质子重离子治疗适合所有可以接受光子治疗(传统放疗)的

上海市委书记出席开业仪式 这家医院何等了得

5月8日,上海市委书记韩正出席一家医院的开业仪式——上海市质子重离子医院暨复旦大学附属肿瘤医院质子重离子中心。名称中彰显浓厚特殊味道的这家医院,究竟有何特殊?独树一帜公开资料显示,运用质子或重离子射线治疗肿瘤,是目前国际公认的最尖端放射治疗技术。该技术也因杀癌效果好和毒副作用小而被誉为“治癌利器”。顾名思义,上海市质子重离子医院便是以这种国际尖端肿瘤放射治疗技术为主要治疗手段的现代化、国际化肿瘤中

Baidu
map
Baidu
map
Baidu
map